{"id":"https://openalex.org/W2247145209","doi":"https://doi.org/10.1182/blood.v122.21.3957.3957","title":"The Survivin Suppressant YM155 (Sepantronium Bromide) Has Potent Pre-Clinical Activity Against Pediatric Acute Myeloid Leukemia","display_name":"The Survivin Suppressant YM155 (Sepantronium Bromide) Has Potent Pre-Clinical Activity Against Pediatric Acute Myeloid Leukemia","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2247145209","doi":"https://doi.org/10.1182/blood.v122.21.3957.3957","mag":"2247145209"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.3957.3957","doi":"https://doi.org/10.1182/blood.v122.21.3957.3957","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.3957.3957","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081039309","display_name":"Erica B. Little","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Erica B. Little","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029749141","display_name":"Amanda M. Smith","orcid":"https://orcid.org/0000-0002-8716-6745","observed_orcids":["https://orcid.org/0000-0002-8716-6745"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Amanda M. Smith","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064265796","display_name":"Andjelija Zivanovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andjelija Zivanovic","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025627019","display_name":"Alfred K.S. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alfred K.S. Liu","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055941261","display_name":"Shannon Waldron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shannon Waldron","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072380645","display_name":"Wendy J. Ingram","orcid":"https://orcid.org/0000-0002-7063-1081","observed_orcids":["https://orcid.org/0000-0002-7063-1081"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Wendy J. Ingram","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110251557","display_name":"Andrew R. Hallahan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew R. Hallahan","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035808651","display_name":"Andrew S. Moore","orcid":"https://orcid.org/0000-0001-8062-1779","observed_orcids":["https://orcid.org/0000-0001-8062-1779"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210121854","display_name":"Queensland Children\u2019s Medical Research Institute","ror":"https://ror.org/02xa7j758","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121854"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew S. Moore","raw_affiliation_strings":["Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4210121854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18348965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"3957","last_page":"3957"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ym155","display_name":"YM155","score":0.9319999814033508},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.8949999809265137},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8960000276565552},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.8420000076293945},{"id":"https://openalex.org/keywords/inhibitor-of-apoptosis-proteins","display_name":"inhibitor of apoptosis proteins","score":0.7960000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.46000000834465027},{"id":"https://openalex.org/keywords/aml-cell-lines","display_name":"AML cell lines","score":0.75},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6100000143051147},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.6909999847412109},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-aml","display_name":"relapsed AML","score":0.5669999718666077},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.3499999940395355},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4059999883174896},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2775975398","wikidata":"https://www.wikidata.org/wiki/Q906904","display_name":"Survivin","level":3,"score":0.8448585867881775},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.7719111442565918},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.7516738176345825},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.675330400466919},{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.6452380418777466},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5739797353744507},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5311017632484436},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5204910635948181},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5180961489677429},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4849534332752228},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.44805997610092163},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3492799997329712},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3454187512397766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30417004227638245},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2621775269508362},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.25209841132164},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09338662028312683}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.3957.3957","doi":"https://doi.org/10.1182/blood.v122.21.3957.3957","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.3957.3957","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991676425","https://openalex.org/W2556211637","https://openalex.org/W2969790862","https://openalex.org/W1611604148","https://openalex.org/W2912255598","https://openalex.org/W3120611629","https://openalex.org/W2177651407","https://openalex.org/W7095193114","https://openalex.org/W2113681251","https://openalex.org/W2162157012"],"abstract_inverted_index":{"Abstract":[0,79],"Despite":[1],"aggressive":[2],"chemotherapy":[3],"and":[4,23,45,59,107,177,229,369,373,383,421,452,456],"a":[5,37,102,122,131,141,155,340,414,442],"high":[6,55],"remission":[7],"induction":[8,401],"rate,":[9],"approximately":[10],"one":[11],"third":[12],"of":[13,57,104,126,144,158,190,214,222,281,288,293,314,321,342,402,417,439,463],"children":[14,350],"with":[15,69,130,154,184,267,285,310,351],"acute":[16],"myeloid":[17],"leukemia":[18],"(AML)":[19],"relapse.":[20],"Therefore,":[21,119],"novel":[22],"more":[24,208],"effective":[25],"treatments":[26],"are":[27],"urgently":[28],"needed.":[29],"Survivin":[30],"is":[31,113,441],"an":[32,299,395],"inhibitor-of-apoptosis":[33],"protein":[34,324],"that":[35,335,436],"plays":[36],"key":[38],"role":[39],"in":[40,73,111,116,128,138,187,201,212,277,301,326,331,388],"regulating":[41],"cell":[42,147,152,171,217,224,236,253,282,294,328,390,419],"division,":[43],"proliferation":[44],"apoptosis":[46],"(Altieri":[47],"et":[48,76,83],"al,":[49,77,84],"Nat":[50],"Rev":[51],"Cancer,":[52],"2008).":[53],"Furthermore,":[54,330],"expression":[56,325],"survivin":[58,89,323,440],"its":[60],"splice":[61],"variants":[62],"have":[63,98],"been":[64,95],"shown":[65],"to":[66,97,182,204,226,386,427,431,465],"be":[67,428],"associated":[68],"poor":[70],"clinical":[71,457],"outcome":[72],"AML":[74,112,146,223,252,327,352,418,425],"(Moore":[75],"ASH":[78],"3555,":[80],"2011;":[81],"Carter":[82],"Blood,":[85],"2012).":[86],"The":[87],"small-molecule":[88],"suppressant":[90],"YM155":[91,127,149,197,316,336,392,408],"(sepantronium":[92],"bromide)":[93],"has":[94,409],"demonstrated":[96,274,334],"pre-clinical":[99,124,411,455],"activity":[100,412],"against":[101,140,339,413],"range":[103,189,357],"solid":[105],"cancers":[106],"leukemias,":[108],"although":[109],"data":[110,434],"limited,":[114],"particularly":[115,180,429,449],"pediatric":[117,134,170],"models.":[118],"we":[120],"undertook":[121],"comprehensive":[123],"evaluation":[125],"AML,":[129,448],"focus":[132],"on":[133],"disease.":[135],"When":[136],"tested":[137,173],"vitro":[139,202,220,332],"diverse":[142,371],"panel":[143,341,416],"9":[145,216],"lines,":[148,391],"potently":[150],"inhibited":[151],"viability":[153,237],"median":[156,243],"IC50":[157,185],"0.03":[159],"\u00b5M":[160],"(range":[161],"0.001":[162],"-":[163,192],"0.680":[164],"\u00b5M;":[165],"Table":[166],"1).":[167],"All":[168],"4":[169],"lines":[172,225,283,420],"(Kasumi-1,":[174],"MV4-11,":[175],"THP-1":[176],"CMK)":[178],"were":[179,361],"sensitive":[181,430],"YM155,":[183,227,286],"values":[186],"the":[188,215,278,311,364],"0.010":[191],"0.053":[193],"\u00b5M.":[194],"Of":[195],"note,":[196],"had":[198,370],"generally":[199],"similar":[200],"efficacy":[203],"daunorubicin,":[205,230],"but":[206],"was":[207,296,337],"potent":[209,410],"than":[210],"cytarabine":[211,228],"7":[213,343],"lines.Table":[218],"1In":[219],"sensitivity":[221],"as":[231,398],"measured":[232,305],"by":[233,298,306,400],"72":[234],"hour":[235],"(resazurin":[238],"reduction)":[239],"assays.":[240],"Values":[241],"indicate":[242],"IC50(\u00b5M)":[244],"from":[245,349,363],"at":[246],"least":[247],"3":[248],"independent":[249],"experiments.":[250],"*Pediatric":[251],"lines.":[254,329],"NS,":[255],"not":[256],"significant.AML":[257],"Cell":[258,271],"LineCharacteristic":[259],"FeatureYM155CytarabineDaunorubicinP":[260],"value":[261],"(YM155":[262],"vs.":[263],"Cytarabine)HL-60Complex":[264],"karyotype0.0010.4810.019NSKasumi-1*t(8;21)(q22;q22)0.0100.1120.0220.011RUNX1-CBFA2T1c-KITmut(N822K)ML-2t(6;11)(q27;q23)0.0100.0620.0050.027OCI/AML3NPM1mut0.011>100.020<0.001MV4-11*t(4;11)(q21;q23)0.0301.2630.004<0.001MLL-AF4FLT3-ITDTHP-1*t(9;11)(p21;q23)0.0367.0440.027<0.001CMK*AML":[265],"assoc.":[266],"Down":[268],"Syndrome0.0530.4280.078<0.001HELAML":[269],"M60.5310.0780.1310.011ME-1inv(16)(p13q22)0.6800.3900.298NSCBFB-MYH11":[270],"cycle":[272],"analyses":[273],"concentration-dependent":[275],"increases":[276],"sub-G1":[279],"fraction":[280],"treated":[284],"suggestive":[287],"apoptosis.":[289],"An":[290],"apoptotic":[291,396],"mechanism":[292,313],"death":[295],"confirmed":[297],"increase":[300],"annexin":[302,403],"V":[303,404],"positivity,":[304],"flow":[307],"cytometry.":[308],"Consistent":[309],"proposed":[312],"action,":[315],"treatment":[317,393],"also":[318],"caused":[319,394],"down-regulation":[320],"total":[322],"assays":[333],"cytotoxic":[338],"primary,":[344],"diagnostic":[345],"bone":[346],"marrow":[347],"samples":[348,360],"(median":[353],"age":[354],"4.8":[355],"years,":[356],"1.3-15.7).":[358],"Patient":[359],"obtained":[362],"Queensland":[365],"Children's":[366],"Tumour":[367],"Bank":[368],"cytogenetic":[372],"molecular":[374],"characteristics,":[375],"including":[376],"CBF-AML,":[377],"monosomy":[378],"7,":[379],"MLL":[380],"gene":[381],"rearrangements":[382],"FLT3-ITD.":[384],"Similar":[385],"experiments":[387],"established":[389],"response,":[397],"evidenced":[399],"positivity.":[405],"In":[406],"conclusion,":[407],"broad":[415],"patient":[422],"samples.":[423],"Pediatric":[424],"appears":[426],"YM155.":[432],"These":[433],"suggest":[435],"YM155-mediated":[437],"inhibition":[438],"potentially":[443],"beneficial":[444],"therapeutic":[445],"strategy":[446],"for":[447],"childhood":[450],"disease,":[451],"warrants":[453],"further":[454],"evaluation.":[458],"Disclosures:":[459],"No":[460],"relevant":[461],"conflicts":[462],"interest":[464],"declare.":[466]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}